Action ATT ABATTIS BIOCEUTICALS CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Autres langues Abattis Bioceuticals Corp. Canadian Securities Exchange

Actions

ATT

CA00258G1037

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019
Abattis Bioceuticals Corp. Announces Board Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of NutriVida Corp.
Abattis Bioceuticals Corp. Reports Earnings Results for the Third Quarter Ended June 30, 2019
Abattis Bioceuticals Corp.'s Equity Buyback announced on August 7, 2018, has expired.
Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2018
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) cancelled the acquisition of Winston Resources Inc..
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) completed the acquisition of Pro Natura BV from The Catalyst Capital Group Inc.
Abattis Bioceuticals : Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
Abattis Bioceuticals Corp. Announces Management Changes
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) agreed to acquire Pro Natura BV from The Catalyst Capital Group Inc. for €15.7 million.
Abattis Bioceuticals Corp. Announces Resignations in Board
British Columbia Securities Commission Removes Temporary Order on Abattis Bioceuticals Corp
Abattis Bioceuticals Corp Announces Launch of Its New Website and Provide an Operational Update
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) signed a letter of intent to acquire NutriVida Corp. for CAD 15 million.
Abattis Bioceuticals Corp Signs a Distribution Agreement with Shefield &Sons Tobacconists Inc. to Sell the Abattis Vaporizer Line in all Shefield &Sons Stores Across Canada
Abattis Bioceuticals Corp. (OTCPK:ATTB.F) acquired Select Strains Inc. for $3.5 million.
Abattis Bioceuticals Corp. Announces Executive Changes
Abattis Intends To Seek Acquisitions
Abattis Bioceuticals Corp. Announces Board Changes
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ATTBF
  4. Action ATT
  5. Actualités Abattis Bioceuticals Corp.
  6. Autres langues